What do Tom Hanks, Rand Paul, Idris Elba, and Boris Johnson have in common? They are just some of the high-profile people to be diagnosed with the COVID-19. Proof that SARS-CoV2 can affect anyone.

The situation is dire. In many places, hospitals are overwhelmed, and the healthcare system is overworked, overburdened, and barely hanging on. Models currently being used by the U.S. government suggest the pandemic will continue into the summer. And there may be a second wave of COVID-19 in the Fall.

But did you know that dozens of leading U.S. research universities are doing widespread research directed to drugs, diagnostics, ventilators and personal protective equipment capable of addressing the immediate pandemic and its next wave? These universities are being deluged with requests from Big Tech and life sciences companies to collaborate, producing a never before seen atmosphere of cooperation. This massive outpouring of innovation and product development is going around the clock because COVID-19 labs and manufacturing are allowed to operate during the lockdown.

Join us for a special free 2-hour webinar conversation. We will discuss the COVID-19 pandemic, the science, what governments are doing, policies that could and should be adopted in order to be in a better position for the next pandemic, or if/when COVID-19 returns, and what you and your team, firm or corporation may be able to do to contribute to this unique global effort.

Speakers Include:

Jeff Blumenfeld
Co-Chair, Antitrust Group
Lowenstein Sandler, LLP

Orin Herskowitz
VP for IP & Tech Transfer
Columbia University

Phil Johnson
Chief IP Officer (ret.)
Johnson & Johnson

David Kappos
Partner, Cravath
Former Director of the USPTOIPWatchdo

Gaby Longsworth
Director
Sterne Kessler

Honorable Paul Michel
Chief Judge (ret.)
Federal Circuit

Rob Sterne
Founding Director
Sterne Kessler

This webinar is part of the IPWatchdog Weekly Webinar Series.

This Webinar is Sponsored By LexisNexis IP